AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

In data from 400 people with type 1 or type 2 diabetes, more time in the normal glucose range on one day was associated with better reported quality of life the next day. Greater glucose variability was also associated with better next-day quality of life, but the researchers say this does not mean poor glucose control is beneficial. The findings are observational and do not show that glucose patterns caused changes in well-being.

A study of 400 people with type 1 or type 2 diabetes found that spending more time in the normal glucose range on one day was associated with better reported quality of life the next day. Researchers also found an association between greater glucose variability and better next-day well-being, a result they said may reflect the burden of trying to suppress every fluctuation. The findings are to be presented at the European Association for the Study of Diabetes (EASD) Annual Meeting in Milan.

Before you orderOffer from Amazon

Get workout gear delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

The analysis used data from the PRO-MENTAL study, funded by the German Center for Diabetes Research. Participants wore continuous glucose monitors and completed daily assessments for 14 consecutive days. Their surveys covered well-being, sleep, perceived stress, mood and energy. Quality of life was assessed using a daily version of the WHO-5 questionnaire, which asks about feelings such as cheerfulness, calm, energy, rest and interest in daily life.

The researchers compared survey responses with several glucose measures: time below 70 mg/dl, time above 180 mg/dl, time in the 70-140 mg/dl range, and glucose variability, which describes how much levels rise and fall. Statistical models examined whether measurements on one day were associated with quality of life the following day. They accounted for age, sex, diabetes type and the previous day’s quality-of-life rating.

The 400 participants included 72% with type 1 diabetes and 28% with type 2; 55% were female. Their median age was 47, with a reported range of 32 to 63, and mean HbA1c was 7.6%. More time in the normal range and greater glucose variability on the prior day were each associated with higher next-day quality-of-life ratings. Time above or below the stated ranges was not significantly associated with next-day quality of life. Better sleep and higher energy on the preceding day were also linked to better next-day well-being. Same-day glucose measures were not associated with same-day quality-of-life ratings.

At a glance
reportWhen: Findings due to be presented at the EAS…
The developmentResearchers analyzing 14 days of glucose-monitor and daily survey data found associations between glucose patterns and next-day quality of life among 400 people with diabetes.

Balancing Glucose Goals and Daily Life

The results raise a question for diabetes care: how can glucose targets support health while leaving room for people to take part in ordinary activities? The study’s authors suggest that some people may find efforts to eliminate every glucose fluctuation burdensome or restrictive, potentially affecting their sense of well-being. That explanation is a possible interpretation of the association, not something the analysis directly measured as a cause.

The findings do not establish that allowing glucose to vary improves quality of life, and they do not advise people to change treatment targets. Instead, they add daily well-being to a discussion often centered on glucose readings. For readers living with diabetes, the distinction matters: the study linked more time in the normal range with better next-day quality of life, while the variability result points to a potential tension researchers say needs further study.

Products Worth Considering

Philips Sonicare 7300 Rechargeable Electric Toothbrush with 3 Brush Heads, Black

Philips Sonicare 7300 Rechargeable Electric Toothbrush with 3 Brush Heads, Black

Oral-B iO5 Rechargeable Electric Toothbrush with 3 Brush Heads and Travel Case

Oral-B iO5 Rechargeable Electric Toothbrush with 3 Brush Heads and Travel Case

Oral-B iO Series 7 Rechargeable Electric Toothbrush, Black, with 2 Brush Heads and Charging Travel Case

Oral-B iO Series 7 Rechargeable Electric Toothbrush, Black, with 2 Brush Heads and Charging Travel Case

As an affiliate, we earn on qualifying purchases.

Fourteen Days of Daily Tracking

Diabetes management involves monitoring glucose alongside treatment decisions and day-to-day routines. Continuous glucose monitors provide readings over time, while measures such as time in range describe how much of that time glucose falls within a specified band. In this study, the researchers treated 70-140 mg/dl as the normal range and used 70 mg/dl and 180 mg/dl as the lower and upper thresholds for the below-range and above-range measures.

The researchers, led by Professor Dominic Ehrmann of FIDAM, the Research Institute Diabetes Academy Mergentheim in Germany, examined whether glucose patterns, sleep, stress, mood and energy could help predict well-being on the following day. They also tested same-day associations. The work is based on repeated observations from participants over two weeks, rather than a trial that assigned people to different glucose-management approaches.

“Days with higher time in the normal safe range for blood sugar were followed by days on which individuals with type 1 and type 2 diabetes reported better quality of life.”

— The study authors

Cause and Daily Burden Remain Unclear

The analysis found associations; it cannot show that glucose variability or time in range caused changes in quality of life. The proposed explanation—that attempts to minimize fluctuations may bring restrictions or added burden—was not established as the mechanism. It is also unclear from the reported findings how large the observed differences in quality-of-life scores were or whether they would be meaningful to participants in daily life.

The study followed participants for 14 days, so the results do not establish whether these patterns persist over longer periods. The report does not describe an intervention or show that changing glucose-management behavior would improve well-being. The findings should not be read as evidence that higher glucose levels or poorer control are beneficial; the authors reported that more time in the normal range was associated with better next-day quality of life.

EASD Presentation and Further Study

The researchers are scheduled to present the findings at the EASD Annual Meeting in Milan, running Sept. 28-Oct. 2, 2026. Further research would be needed to test why glucose variability was associated with next-day well-being, whether the relationship holds over longer periods, and how it varies among people with different treatment needs and routines. The reported study does not specify a next research milestone.

For now, the results describe patterns in daily monitoring and surveys. They do not provide a basis for individuals to alter glucose targets or treatment. Any personal treatment decisions remain a matter to discuss with a diabetes care professional.

Key Questions

What did the diabetes study find?

Among 400 participants, more time in the normal glucose range and greater glucose variability on one day were each associated with better reported quality of life the following day.

Does the finding mean glucose variability is beneficial?

No. The study found an association, not proof that variability improves well-being. The authors said the result may relate to the burden or restrictions of trying to minimize fluctuations, but that explanation remains unconfirmed.

Did high or low glucose levels predict next-day well-being?

Time spent above 180 mg/dl or below 70 mg/dl was not significantly associated with next-day quality of life in this analysis. More time in the study’s 70-140 mg/dl normal range was associated with better next-day ratings.

How was quality of life measured?

Participants completed daily assessments for 14 days using a version of the WHO-5 questionnaire, alongside ratings of sleep, stress, mood and energy.

Should people change their diabetes treatment because of this study?

The findings do not show that changing treatment targets would improve quality of life. People should discuss personal glucose goals and treatment decisions with their diabetes care professional.

Source: rss

Wellness content on this site is informational and not a substitute for professional medical guidance.
You May Also Like

More New Moms Are Starting GLP-1 Drugs

A U.S. claims analysis found postpartum GLP-1 starts climbed from 2018 to 2025; most recent users did not have type 2 diabetes.

Streamed Execution Sparks PTSD Concerns; 17% Of Teens Anxious; Actor Dies Of Suicide

A psychiatry roundup reports anxiety symptoms among U.S. teens and concerns over a proposed streamed execution, alongside other mental health findings.

Does Creatine Make You Smarter?

New studies investigate whether creatine supplementation can improve intelligence and brain performance, with current findings showing mixed results.

Cyclosporiasis Foods To Avoid

Health officials warn against consuming certain fresh produce linked to a cyclosporiasis outbreak. Stay informed on which foods to avoid and why it matters.